Mark R. Hake

Mark R. Hake

CFA

Mark R. Hake, CFA is a financial analyst and entrepreneur. He has been a Chartered Financial Analyst (CFA) for 31 years and has owned his own investment management and investment research firms that focused on value stocks, both in the U.S. and overseas.

Mark writes over 600 articles per year on stocks, cryptos, SPACs, convertibles, ETFs, and other financial securities. He has been ranked with 5 stars by TipRanks.com (under “Mark R. Hake”) with an average return of over 22% annually and #36 out of 8,116 writers. Presently he authors articles on Medium.com and other sites.

Mark also invests in public and private equities and has acted as a hedge fund manager and portfolio manager for various money management firms. He has also acted as CFO and Chief Strategy Officer for several fin-tech and software companies.

You can follow Mark on LinkedIn and on TipRanks.

Recent Articles

United Airlines Is Still Undervalued, Given Its Recovery Potential

By Mark R. Hake, CFA

It won't be long before analysts will start predicting profits for United Airlines for 2022. UAL stock is undervalued and is a "buy" now.

Occidental Petroleum is Cheap Due to its Debt Load but Will Turn Around

By Mark R. Hake, CFA

Occidental Petroleum is cheap due to its debt load. OXY stock trades for less than its common stock tangible book value but will be worth more when oil turns around.

General Motors Is Slowly Making Progress With EVs

By Mark R. Hake, CFA

General Motors is slowly making progress with EVs but it's a long road ahead. GM stock is worth at least 135% more than today, given its average P/E ratio and analysts' expectations for next year.

Undervalued Alibaba Stock Could Easily Double in Price

By Mark R. Hake, CFA

Alibaba stock is greatly undervalued. In fact, the numbers show that a patient investor could be rewarded with a return greater than 100%.

Nokia Stock Still Looks Attractive Given Its New CEO and Likely Shakeup

By Mark R. Hake, CFA

Nokia's new CEO and management may shake things up, which could push Nokia stock up 50% to its target price.

Stay Away From Sorrento Therapeutics Here

By Mark R. Hake, CFA

Sorrento Therapeutics looks overvalued here. Investors in SRNE stock can expect dilution from equity/debt raises, given the company's ongoing burn rate and deals.

Ford Is Still Undervalued, But its New CEO May Change This

By Mark R. Hake, CFA

Ford is still undervalued but its new CEO may change things. I think F stock is worth at least $8.40 if it resumes its 60-cent annual dividend next year.

Workhorse Stock Is on Track to Be an EV Winner

By Mark R. Hake, CFA

Workhorse stock is on track to be an EV winner. WKHS stock is worth at least 20% more or $23.71 per share, given expected sales, and its stake in Lordstown Motors.

4 SPAC Stocks With New Mergers and 2 Pre-Merger SPACs Worth a Look

By Mark R. Hake, CFA

These 4 SPAC stocks recently announced merger deals and most offer upside from 33% to over 100%. Plus, 2 pre-merger SPACs to consider.

Pfizer Stock Will Soar With Its First-Mover Vaccine Advantage

By Mark R. Hake, CFA

Pfizer will have first-mover advantage with its Covid-19 vaccine. But that is not the only reason to be bullish on PFE stock.

Load More